Search clinical trials for: Drug eluting absorbable metal scaffold

Total 260344 results

Biotronik AG
Biotronik AG

Not yet recruiting

Safety and Clinical Performance of the DREAMS 3G Resorbable Magnesium Scaffold System (BIOMAG-II)

Myocardial Ischemia | Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Ischemic Heart Disease | Atherosclerosis, Coronary
Biotronik AG

Unknown

First in Man Study of the DREAMS 2nd Generation Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-II) (BIOSOLVE-II)

Coronary Artery Disease | Coronary Artery Stenosis

Spain, Denmark, Germany, Brazil, Belgium, Netherlands, Singapore, Switzerland
Biotronik AG

Completed

Pre-market Study of the DREAMS 2G Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-III) (BIOSOLVE-III)

Coronary Artery Disease | Coronary Artery Stenosis

Germany, Belgium, Netherlands, Switzerland
Biotronik AG
CBCC-VIBGYOR Research Pvt. Ltd.

Suspended

Safety and Clinical Performance of a Sirolimus-eluting Absorbable Metal Scaffold (BIOSOLVE-India)

Coronary Artery Disease

India
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

A First-in-Man Study of the Firesorb BVS (FUTURE-I) (FUTURE-I)

Coronary Artery Disease

China
Deutsches Herzzentrum Muenchen

Unknown

A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction (ISAR-Absorb MI)

Myocardial Infarction | Cardiovascular Disease | Thrombus | Primary Angioplasty

Germany
Institut d'Investigació Biomèdica de Bellvitge
Fundació La Marató de TV3

Completed

Comparison of the Vasomotor Function and Myocardial Flow in Patients Treated With Bioresorbable and Metallic Stents at 1 Year (BVS-Flow)

Stable Angina

Spain
Yonsei University

Unknown

A Randomized Comparison of Clinical Outcomes Between Everolimus-eluting Bioresorbable Vascular Scaffold Versus Everolimus-eluting Metallic Stent in Long Coronary Lesions

Coronary Artery Disease

Korea, Republic of
Duk-Woo Park, MD
CardioVascular Research Foundation, Korea

Terminated

Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease (ABSORB-LONG)

Percutaneous Transluminal Coronary Angioplasty

Korea, Republic of
R3 Vascular Inc.

Recruiting

Evaluation of the MAGNITUDE® Bioresorbable Drug-Eluting Scaffold in the Treatment of Patients With Below the Knee Disease in Australia (MAGNITUDE-BTK)

Critical Limb Ischemia | Critical Lower Limb Ischemia | Critical Limb-Threatening Ischemia

Australia
R3 Vascular Inc.

Not yet recruiting

Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease (ELITE-BTK)

Chronic Limb-Threatening Ischemia
Biotyx Medical (Shenzhen) Co., Ltd.
VascuScience GmbH; Mediolanum Cardio Research Srl; Euroimage Research Srl

Recruiting

IBS Titan™ Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System Clinical Trial

Critical Limb Ischemia | Infrapopliteal Lesions

Italy
General Administration of Military Health, Tunisia
B. Braun Medical International Trading Company Ltd.

Recruiting

Drug Eluting Balloon Angioplasty Versus Everolimus Platinum Chrome Stent (DEBATE)

Coronary Artery Disease (CAD) | De Novo Stenosis | Percutaneous Coronary Intervention (PCI)

Tunisia
Shandong Branden Med.Device Co.,Ltd
Shandong Rientech Medical Tech Co., Ltd.

Not yet recruiting

Study on Absorbable Zinc Alloy Drug Eluting Coronary Stent System

Coronary Heart Disease | Drug Eluting Stent
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Non-inferiority Clinical Trial to Compare the Safety and Performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions (MeRethonRCT)

Coronary Artery Disease
REVA Medical, Inc.

Recruiting

MOTIV BTK Randomized Controlled Trial

Critical Limb Ischemia

United States, Germany
R3 Vascular Inc.
Cardiovascular Research Foundation, New York; Massachusetts General Physicians...

Recruiting

Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease (RESOLV I)

Peripheral Arterial Disease | Lower Extremity Claudication | Lower Extremity Ischemia | Atherosclerotic Lesion

Canada, Italy, Austria
Biotyx Medical (Shenzhen) Co., Ltd.

Recruiting

IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease (GENIUS)

Critical Limb Ischemia (CLI)

China
Biotronik AG

Recruiting

Resorbable Magnesium Scaffolds Registry

Coronary Artery Disease

Germany
University Hospital Ulm

Recruiting

Coronary Interventions Ulm - Coronary Chronic Total Occlusions (CSI)

Chronic Total Occlusion | Chronic Total Occlusion of Coronary Artery

Germany
Joost Daemen
Horizon 2020 - European Commission; REVA Medical, Inc.

Recruiting

FANTOM ENCORE Sirolimus-eluting Bioresorbable Scaffold for Treatment of De-novo CAD: the ENCORE-I Study

Percutaneous Coronary Intervention | Tomography, Optical Coherence | Myocardial Revascularization

Netherlands, Belgium
Shanghai Bio-heart Biological Technology Co., Ltd.
CCRF Inc., Beijing, China

Not yet recruiting

A Registry Trial of The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System

Coronary Artery Disease

China
Lifetech Scientific (Shenzhen) Co., Ltd.

Recruiting

A First-in-Man Study to Evaluate the Feasibility and Safety of Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System

Single Coronary Vessel Disease

Malaysia
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Study of MeRes100 in the Treatment of Patient With Coronary Artery Disease. (MeReS100-China)

Coronary Artery Disease
Samsung Medical Center

Withdrawn

DEB Versus 2nd Generation DES in Patients With In-Scaffold Restenosis of Bioresorbable Vascular Scaffold (SMART-BRS-ISR)

Coronary Artery Disease | Coronary Restenosis

Korea, Republic of
Abbott Medical Devices

Active, not recruiting

LIFE-BTK PK Sub-study

Critical Limb Ischemia (CLI)

Taiwan, United States, Australia
Duk-Woo Park, MD
CardioVascular Research Foundation, Korea

Terminated

Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice (IRIS BVS)

Cardiovascular Diseases | Coronary Artery Disease | Coronary Disease | Arterial Occlusive Diseases

Korea, Republic of
Abbott Medical Devices

Active, not recruiting

LIFE-BTK Randomized Controlled Trial (LIFE-BTK)

Critical Limb Ischemia (CLI)

United States, Hong Kong, Australia, New Zealand, Singapore, Taiwan
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque (PREVENT)

Coronary Artery Disease | Plaque, Atherosclerotic

Korea, Republic of, Taiwan, United States, Japan, New Zealand
Abbott Medical Devices

Completed

Absorb IV Randomized Controlled Trial

Coronary Artery Disease | Coronary Disease | Coronary Stenosis | Coronary Artery Stenosis

United States, Canada, Australia, Germany, Singapore
Abbott Medical Devices

Completed

ABSORB III Randomized Controlled Trial (RCT) (ABSORB-III)

Coronary Artery Disease | Coronary Disease | Coronary Stenosis | Coronary Artery Stenosis

United States, Australia
Biotyx Medical (Shenzhen) Co., Ltd.

Active, not recruiting

A Clinical Investigation to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease (IRONMAN-II)

Coronary Artery Disease

China
Biotyx Medical (Shenzhen) Co., Ltd.

Active, not recruiting

A Clinical Trial to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease (IRONMAN-III)

Coronary Artery Disease

China
Skane University Hospital

Completed

Drug Eluting Stent Zilver PTX vs Bare Metal Stent Zilver Flex

Vascular Diseases
Abbott Medical Devices

Completed

Absorb GT1 Japan PMS

Myocardial Ischemia | Coronary Artery Disease | Angina Pectoris | Ischemic Heart Disease | Coronary Artery Occlusion

Japan
Phillip Freeman
Odense University Hospital; Aarhus University Hospital; Biosensors International and other collaborators

Active, not recruiting

Sort Out XI - Combo Stent Versus BioMatrix Alpha Stent (SORTOUTXI)

Coronary Artery Disease

Denmark
REVA Medical, Inc.

Active, not recruiting

Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold (FANTOM II)

Coronary Artery Disease

Netherlands, Denmark, Poland, Germany, Australia, France, Belgium, Brazil
VA Office of Research and Development

Completed

Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty (DIVA)

Saphenous Vein Graft Atherosclerosis

United States
Biotronik AG

Active, not recruiting

First in Men Study: BIOMAG-I

Coronary Artery Disease

Austria, Spain, Belgium, Poland, Sweden, Germany, Netherlands, Switzerland
Groupe Hospitalier de la Rochelle Ré Aunis
BBraun Medical SAS

Active, not recruiting

Safety Assessment of Angioplasty Procedures (SCRAP)

Angiospastic; Disorder

France
University Hospital, Grenoble

Completed

MGuard Stent and Microcirculation (GUARDIANCORY)

Cardiovascular Diseases | Coronary Artery Disease | Coronary Disease | Coronary Atherosclerosis

France
A.O. Ospedale Papa Giovanni XXIII
Medtronic; Case Western Reserve University

Completed

Vessel Wall Response of the Zotarolimus Drug-eluting Stent Implanted in AMI Assessed by Optical Coherence Tomography (OCTAMI)

Acute Myocardial Infarction

Italy
Papworth Hospital NHS Foundation Trust

Completed

Coronary Microcirculatory and Bioresorbable Vascular Scaffolds (EMPIRE-BVS)

Myocardial Ischemia | Angina, Stable | CHD - Coronary Heart Disease

United Kingdom
IHF GmbH - Institut für Herzinfarktforschung
Abbott Medical Devices

Completed

Observational Study to Evaluate Short and Long-term Safety of the ABSORB Scaffold (GABI-R)

Coronary Artery Stenosis

Germany, Austria
Hospital Regional Tlalnepantla

Completed

Femur Transtrochanteric Fractures Treated With Dynamic Hip Screw and Calcium Sulfate Scaffold. (geneX)

Proximal Femur Fracture
University of Freiburg

Completed

Comparison of Everolimus- and Biolimus-Eluting Stents With Everolimus-Eluting Bioresorbable Vascular Scaffold Stents (EVERBIOII)

Coronary Artery Disease

Switzerland
Universita di Verona

Completed

Safety and Efficacy of Everolimus - Eluting Bioresorbable Vascular Scaffold for Cardiac Allograft Vasculopathy (CART)

Cardiac Allograft Vasculopathy

Italy, Netherlands
Lifetech Scientific (Shenzhen) Co., Ltd.

Active, not recruiting

A First-in-Man Study of IBS (IBS-FIM)

Single Coronary Vessel Disease

China
Duk-Woo Park, MD
CardioVascular Research Foundation, Korea

Terminated

IRIS-BVS AMI Registry (IRIS BVS AMI)

Cardiovascular Diseases | Coronary Artery Disease | Arterial Occlusive Diseases

Korea, Republic of
Jung-min Ahn
CardioVascular Research Foundation, Korea

Withdrawn

The Usefulness of Coronary CT Scan After Everolimus-eluting Bioabsorbable Scaffold Implantation for Coronary Artery Disease (CT BVS)

Coronary Disease

Korea, Republic of

Search clinical trials for: Drug eluting absorbable metal scaffold

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations